Polyclonal Antibody to Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP)
MAC-2-BP; LGALS3-BP; Galectin-3-Binding Protein; L3 Antigen; Mac-2-Binding Protein; Tumor-associated antigen 90K; Serum Protein 90K; Basement membrane autoantigen p105
- Product No.PAB766Hu01
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- SourcePolyclonal antibody preparation
- HostRabbit
- Potencyn/a
- Ig Type IgG
- PurificationAntigen-specific affinity chromatography followed by Protein A affinity chromatography
- LabelNone
- Immunogen RPB766Hu01-Recombinant Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP)
- Buffer FormulationPBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
- TraitsLiquid
- Concentration0.5mg/mL
- Organism Species Moren/a
- ApplicationsWB; IHC
 If the antibody is used in flow cytometry, please check FCM antibodies.
- DownloadInstruction Manual
- UOM 20µl100µl 200µl 1ml 10ml
- FOB
    
                                    US$ 100 
            
                
                        US$ 232 
                                        US$ 332 
                                        US$ 830 
                                        US$ 3320 
                            
 For more details, please contact local distributors!
SPECIFITY
The antibody is a rabbit polyclonal antibody raised against LGALS3BP. It has been selected for its ability to recognize LGALS3BP in immunohistochemical staining and western blotting.
USAGE
        Western blotting: 0.01-3µg/mL;
Immunohistochemistry: 5-30µg/mL;
Immunocytochemistry: 5-30µg/mL;
Optimal working dilutions must be determined by end user.    
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
GIVEAWAYS
INCREMENT SERVICES
- 
                     Antibody Labeling Customized Service Antibody Labeling Customized Service
- 
                     Protein A/G Purification Column Protein A/G Purification Column
- 
                     Staining Solution for Cells and Tissue Staining Solution for Cells and Tissue
- 
                     Positive Control  for Antibody Positive Control  for Antibody
- 
                     Tissue/Sections Customized Service Tissue/Sections Customized Service
- 
                     Phosphorylated Antibody Customized Service Phosphorylated Antibody Customized Service
- 
                     Western Blot (WB) Experiment Service Western Blot (WB) Experiment Service
- 
                     Immunohistochemistry (IHC) Experiment Service Immunohistochemistry (IHC) Experiment Service
- 
                     Immunocytochemistry (ICC) Experiment Service Immunocytochemistry (ICC) Experiment Service
- 
                     Flow Cytometry (FCM) Experiment Service Flow Cytometry (FCM) Experiment Service
- 
                     Immunoprecipitation (IP) Experiment Service Immunoprecipitation (IP) Experiment Service
- 
                     Immunofluorescence (IF) Experiment Service Immunofluorescence (IF) Experiment Service
- 
                     Buffer Buffer
- 
                     DAB Chromogen Kit DAB Chromogen Kit
- 
                     SABC Kit SABC Kit
- 
                     Long-arm Biotin Labeling Kit Long-arm Biotin Labeling Kit
- 
                     Real Time PCR Experimental Service Real Time PCR Experimental Service
| Magazine | Citations | 
| Andrology | Comparative proteomic analysis coupled with conventional protein assay as a strategy to identify predictors of successful testicular sperm extraction in patients with non-obstructive azoospermia PubMed: 23427166 | 
| Liver International | Identification of candidate biomarkers for hepatocellular carcinoma in plasma of HCV-infected cirrhotic patients by 4-D DIGE Pubmed: 23944848 | 
| Acta Anaesthesiologica Scandinavica | Early prognostic factors in septic shock cancer patients: a prospective study with a proteomic approach Pubmed:29315472 | 
 
         
 
                             
                             
                             
                             
                             
                             
                             
                            

 
    